Patents Assigned to Cell Viable Corporation
  • Patent number: 9040553
    Abstract: The present invention provides a process for the synthesis of substituted phenoxymethylpropionic acid and related compounds. The compounds are useful for inhibiting the formation of AGEs (Advanced Glycation End Products).
    Type: Grant
    Filed: July 11, 2013
    Date of Patent: May 26, 2015
    Assignee: CELL VIABLE CORPORATION
    Inventors: Iraj Lalezari, Jill Fabricant
  • Publication number: 20120071502
    Abstract: The present invention provides a process for the synthesis of substituted phenoxymethylpropionic acid and related compounds. The compounds are useful for inhibiting the formation of AGEs (Advanced Glycation End Products).
    Type: Application
    Filed: September 13, 2011
    Publication date: March 22, 2012
    Applicant: CELL VIABLE CORPORATION
    Inventors: Iraj Lalezari, Jill Fabricant
  • Patent number: 8053449
    Abstract: Various methods of administering medication(s) that inhibit the nonenzymatic formation of glycation and dehydration condensation complexes known as advanced glycation end-products (AGEs) or modulate the advanced glycation end-product receptor (RAGE) are provided. Also, a medication releasing medical devices, wherein at least a portion of the medical device releasably includes at least one of these medication(s) are provided.
    Type: Grant
    Filed: October 2, 2006
    Date of Patent: November 8, 2011
    Assignee: Cell Viable Corporation
    Inventor: Jill D. Fabricant
  • Patent number: 8048896
    Abstract: Various methods of administering medication(s) that inhibit the nonenzymatic formation of glycation and dehydration condensation complexes known as advanced glycation end-products (AGEs) or modulate the advanced glycation end-product receptor (RAGE) are provided.
    Type: Grant
    Filed: December 6, 2007
    Date of Patent: November 1, 2011
    Assignee: Cell Viable Corporation
    Inventor: Jill D. Fabricant
  • Patent number: 8034966
    Abstract: The present invention provides a process for the synthesis of substituted arylureidophenoxymethylpropionic acid and related compounds including bifunctional and tetrafunctional derivatives. The compounds are useful for inhibiting the formation of AGEs (Aminaglycation end products).
    Type: Grant
    Filed: May 15, 2009
    Date of Patent: October 11, 2011
    Assignee: Cell Viable Corporation
    Inventors: Iraj Lalezari, Jill Fabricant